and standalone influenza vaccines. The FDA lifted a clinical hold that had been placed on Novavax's investigational new drug application after the company addressed concerns related to a serious ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...

Aug. 15, 2024 — A unique influenza vaccine candidate that's inhaled appears safe and could bolster protection against seasonal and pandemic influenza for people ... New Two-Step Flu Vaccine ...

Two strains of influenza A, H1N1 and H3N2, affect people. Scientists always include these strains in the annual flu vaccine. Influenza A viruses are the ones that have been responsible for global ...

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

Zhang V, Zhu P, Wagner AL. Spillover of vaccine hesitancy into adult COVID-19 and influenza: the role of race, religion, and political affiliation in the United States. Int J Environ Res Public ...

Animal health companies are developing vaccines that improve the breadth and effectiveness of protection against avian ...

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.